Fagron bolsters EMEA footprint with acquisitions of Amara and Magilab
BRUSSELS: Belgian pharmaceutical compounding firm Fagron said on Monday it had acquired the business of Poland’s Amara and Hungary’s Magilab to strengthen its position in the EMEA region, part of a strategy to diversify in dynamic markets. The company also said it had secured a new $225 million U.S. credit facility and received a key…